XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Condensed Statements of Earnings and Comprehensive Income - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2022
Oct. 01, 2021
Sep. 30, 2022
Oct. 01, 2021
Sales $ 788.0 $ 768.5 $ 2,312.5 $ 2,200.5
Cost of sales (428.1) (422.1) (1,269.2) (1,223.8)
Gross profit 359.9 346.4 1,043.3 976.7
Operating costs:        
Selling, general and administrative expenses (174.7) (147.8) (517.4) (458.1)
Research and development expenses (35.0) (31.2) (104.4) (97.3)
Operating profit 150.2 167.4 421.5 421.3
Non-operating income (expense), net:        
Interest expense, net (17.9) (12.0) (46.1) (34.4)
Write-off of deferred financing costs 0.0 0.0 0.0 (3.4)
Gain on settlement of investment 0.0 3.2 0.0 3.2
Gain on previously held equity interests from combination of business 0.0 0.0 32.7 0.0
Unrealized (loss)/gain on equity securities measured at fair value (65.8) 0.0 17.2 0.0
Other non-operating income (expense), net 1.4 (0.2) 1.3 (0.3)
Earnings before income taxes 67.9 158.4 426.6 386.4
Provision for income taxes (17.8) (31.1) (93.0) (85.8)
Net earnings $ 50.1 $ 127.3 $ 333.6 $ 300.6
Net earnings per share:        
Basic (in dollars per share) $ 0.32 $ 0.75 $ 2.07 $ 1.78
Diluted (in dollars per share) $ 0.32 $ 0.75 $ 2.06 $ 1.77
Average common stock and common equivalent shares outstanding:        
Basic (in shares) 158.2 169.1 161.5 168.9
Diluted (in shares) 158.7 170.3 162.2 170.0
Net earnings $ 50.1 $ 127.3 $ 333.6 $ 300.6
Other comprehensive income (loss), net of income taxes:        
Foreign currency translation adjustments (44.7) (7.0) (122.9) (24.7)
Other adjustments 0.0 0.2 0.2 0.3
Total other comprehensive loss, net of income taxes (44.7) (6.8) (122.7) (24.4)
Comprehensive income 5.4 120.5 210.9 276.2
Sales of products        
Sales 707.7 699.7 2,080.5 2,005.1
Cost of sales (373.0) (371.8) (1,115.8) (1,067.3)
Sales of services        
Sales 80.3 68.8 232.0 195.4
Cost of sales $ (55.1) $ (50.3) $ (153.4) $ (156.5)